Cardiovascular Diseases

Finerenone Reduced CV Events and CKD Progression

A randomized, double-blind, placebo-controlled trial in chronic kidney disease (CKD) and type 2 diabetes (T2D) concluded that treatment with finerenone reduced risks of CKD progression and cardiovascular (CV) events. Between September 2015 and June 2018, 5734 patients with CKD and T2D were randomly assigned in a 1:1 ratio to receive finerenone (a nonsteroidal, selective mineralocorticoid receptor antagonist) or placebo. Compared to placebo, finerenone reduced the risk of the composite CKD (kidney failure, a sustained decrease of at least 40% in the eGFR from baseline, or death from renal causes, hazard ratio 0.82), and CV (CV death, myocardial infarction, stroke, or hospitalization for heart failure, hazard ratio 0.86) outcomes over a median follow-up of 2.6 years. Overall, the frequency of adverse events was similar in the two groups, although the incidence of hyperkalemia-related discontinuation of the trial regimen was higher with finerenone than with placebo (2.3% and 0.9%, respectively). The findings support finerenone to be a meaningful treatment option for patients with CKD and T2D, in addition to control of hypertension and hyperglycemia, a renin–angiotensin system blocker and, more recently, a sodium–glucose cotransporter 2 inhibitor. Source: https://www.nejm.org/; https://www.ahajournals.org/

hyangiu

Recent Posts

4:3 Intermittent Fasting Outperforms Daily Caloric Restriction for Weight Loss

A U.S. randomized clinical trial found that 4:3 intermittent fasting (IMF) led to slightly greater…

1 day ago

Comparative CVD Efficacy of Newer Glucose-Lowering Drugs in Elderly T2D Patients

A Danish nationwide cohort study provided real world evidence that both glucagon-like peptide 1 receptor…

6 days ago

Efficacy of Non-Surgical and Non-Interventional Treatments in Low Back Pain

A systematic review and meta-analysis of placebo-controlled randomized trials showed that there is moderate certainty…

2 weeks ago

Statin Use Linked to Lower Risks of HCC and Liver Disease Progression

A US cohort study indicated that statin use may reduce the risks of hepatocellular carcinoma…

2 weeks ago

Clinical Significance of Carotid Artery Plaque with Age and Sex

A US cohort study suggests that carotid artery plaque (CAP) becomes very common with increasing…

3 weeks ago

Substituting Butter with Plant-Based Oils May Improve Survival

A prospective US population-based cohort study suggested that higher intake of butter was associated with…

4 weeks ago

This website uses cookies.